Inotuzumab ozogamicin and Mesalamine Controlled-Release Capsules
Determining the interaction of Inotuzumab ozogamicin and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Mesalamine Delayed Release Tablets
- Inotuzumab ozogamicin-Mesalamine Long-Acting Capsules (Apriso)
- Inotuzumab ozogamicin-Mesalamine Long-Acting Capsules (Delzicol)
- Inotuzumab ozogamicin-Mesalamine Long-Acting Capsules (Pentasa)
- Inotuzumab ozogamicin-Mesalamine rectal
- Inotuzumab ozogamicin-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Inotuzumab ozogamicin Intravenous
- Mesalamine Controlled-Release Capsules-Inova
- Mesalamine Controlled-Release Capsules-Inova 4/1 topical
- Mesalamine Controlled-Release Capsules-Inova 8/2 topical
- Mesalamine Controlled-Release Capsules-Inova ACT
- Mesalamine Controlled-Release Capsules-Inrebic